Your browser doesn't support javascript.
loading
Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.
Adema, Vera; Palomo, Laura; Toma, Andrea; Kosmider, Olivier; Fuster-Tormo, Francisco; Benito, Rocío; Salgado, Rocío; Such, Esperanza; Larrayoz, María José; Xicoy, Blanca; Hernandez-Sanchez, Jesus Maria; Maietta, Paolo; Neef, Alexander; Fontenay, Michaela; Ibañez, Mariam; Diez-Campelo, Maria; Alvarez, Sara; Maciejewski, Jaroslaw P; Fenaux, Pierre; Sole, Francesc.
Afiliação
  • Adema V; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
  • Palomo L; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Toma A; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
  • Kosmider O; Assistance Publique - Hôpitaux de Paris, Service Hematologie Clinique, Hôpital Universitaire Henri Mondor, Creteil, France.
  • Fuster-Tormo F; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.
  • Benito R; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
  • Salgado R; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.
  • Such E; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
  • Larrayoz MJ; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Xicoy B; Laboratorio de Citogenetica, Servicio de Hematología, Hospital Universitario fundación Jimenez Díaz, Madrid, Spain.
  • Hernandez-Sanchez JM; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Maietta P; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.
  • Neef A; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Fontenay M; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Ibañez M; Department of Genetics, School of Medicine, University of Navarra, IDISNA, Pamplona, Spain.
  • Diez-Campelo M; Hematology Service, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain.
  • Alvarez S; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.
  • Maciejewski JP; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
  • Fenaux P; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Sole F; Scientific & Innovation Department, Nimgenetics, Madrid, Spain.
Br J Haematol ; 189(4): e133-e137, 2020 05.
Article em En | MEDLINE | ID: mdl-32147816
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Lenalidomida Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Lenalidomida Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha